Television Show to Feature Skinvisible Licensee Safe4Hours(R) With Invisicare(R)



    
    - Marketing Efforts Continue to Expand in Canada
    

    LAS VEGAS, April 27 /CNW/ -- Skinvisible, Inc. (OTC Bulletin Board:   SKVI)
(Website: www.skinvisible.com) and its licensee JD Nelson & Associates are
pleased to announce its antimicrobial sanitizing lotion/skin protectant
product Safe4Hours(R) will be featured on "Daytime," a Canadian television
show produced by Rogers Television.  This program is a daily magazine-style
television series which features local stories and lifestyle segments. 
Safe4Hours will be highlighted in a gardening segment that will air at 11:00
a.m., 5:00 p.m. and 11:00 p.m. EDT today, Friday, April 27th.
    
    (Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)
    (Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)
    
    "Independent studies have verified that Safe4Hours acts as both a
sanitizing lotion and a skin barrier against the absorption of noxious
chemicals into the skin.  This includes guarding against many of the
pesticides and insecticides used in gardening today.  The television feature
on gardening will show how people who work outdoors can protect themselves by
using Safe4Hours," said Mr. Doug Nelson, President and CEO of JD Nelson &
Associates.  "We are pleased with the positive feedback we have had from the
television program's producers about the benefits of using Safe4Hours, and
anticipate a very positive and beneficial story for consumers."
    "Using Safe4Hours while gardening protects the gardener from the
chemicals that lurk in the soil, plants and debris," said Mr. Terry Howlett,
President and CEO of Skinvisible.  "This television show is a great platform
to inform people about the dangers of various chemicals and how they can
protect themselves by applying Safe4Hours before they begin their outdoor
projects. We are very pleased with receiving media exposure like this and know
that it will assist JD Nelson & Associates in making progress in the Canadian
market."
    Skinvisible's business model is focused on licensing its proprietary
formulations with Invisicare to pharmaceutical and cosmeceutical companies as
well as assisting companies in revitalizing or enhancing their existing skin
care products.

    
    About Invisicare(R)
    
    Skinvisible has patented its technology and trademarked its polymer
delivery system Invisicare(R).  Invisicare is a combination of hydrophilic and
hydrophobic polymers that hold active ingredients on the skin for extended
periods of time.  They are non-occlusive and allow normal skin respiration and
perspiration while moisturizing and protecting against exposure from a wide
variety of environmental irritants. See: www.invisicare.com

    
    About Skinvisible Pharmaceuticals, Inc.
    
    Skinvisible Pharmaceuticals is a research-and-development company whose
primary business objective is to license its proprietary formulations with
Invisicare(R) to pharmaceutical and cosmeceutical companies as well as
assisting companies in revitalizing or enhancing their existing skin care
products.  Skinvisible receives a combination of research and development
fees, upfront license fees, and ongoing royalties for the life of the
Invisicare patent.  See www.skinvisible.com

    
    About JD Nelson & Associates
    
    Located in Columbus, Ohio and Toronto, CA. JD Nelson specializes in
manufacturing, marketing and distributing consumer products.  J. Douglas
Nelson, President& CEO and Fred A. Dobson, Vice President of Sales and
Marketing, together have over 46 years of marketing and distribution
experience.

    
    Forward-Looking Statements
    
    This press release contains 'forward looking' statements within the
meaning of Section 21A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, and are subject to the
safe harbors created thereby.  Such statements involve certain risks and
uncertainties associated with an emerging company.  Actual results could
differ materially from those projected in the forward looking statements as a
result of risk factors discussed in Skinvisible, Inc. reports on file with the
U.S. Securities and Exchange Commission (including, but not limited to, a
report on Form 10K for the year ending December 31, 2006.)

    
    Corporate Contact:
    Terry Howlett, President/CEO
    Skinvisible Pharmaceuticals, Inc.
    Phone: 702-433-7154
    Email: info@skinvisible.com

    




For further information:

For further information: Terry Howlett, President/CEO of Skinvisible 
Pharmaceuticals, Inc., +1-702-433-7154, info@skinvisible.com Web Site:
http://www.skinvisible.com                  http://www.invisicare.com

Organization Profile

SKINVISIBLE, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890